Skip to main content

Table 5 Between- and within-subjects variability in the annual change in bronchodilator response expressed as absolute, relative and percent predicted changes 1

From: Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD

 

Response measured by absolute change in FEV (ml)

Response measured by absolute change in FVC (ml)

Tiotropium

Placebo

Tiotropium

Placebo

Between-subject variability in annual change (square-root of variance)

15.2

15.3

30.2

44.5

Within-subject variability (square-root of variance)

109.2

107.9

244.7

252.0

 

Response measured by % change in FEV (ml)

Response measured by % change in FVC (ml)

Tiotropium

Placebo

Tiotropium

Placebo

Between-subject variability in annual change (square-root of variance)

1.44

1.65

1.43

1.98

Within-subject variability (square-root of variance)

11.3

12.0

11.0

12.4

 

Response measured by absolute change in FEV (% predicted)

Response measured by absolute change in FVC (% predicted)

Tiotropium

Placebo

Tiotropium

Placebo

Between-subject variability in annual change (square-root of variance)

0.55

0.54

0.89

1.26

Within-subject variability (square-root of variance)

3.93

3.88

7.04

7.23

  1. 1The variations were estimated from the linear mixed effects models.